US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Neuroscience and Healthcare ETF

38.95

-0.4244-1.08%

Volume:893

Turnover:34.81K

Market Cap:7.79M

PE:- -

High:38.97

Open:38.97

Low:38.95

Close:39.37

52wk High:43.01

52wk Low:25.42

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.23

T/O Rate:0.45%

Dividend:0.32

Dividend Rate:0.82%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Netherlands' Argenx Q2 Net Sales Rise

Neuralink's Soaring Valuation Ignites the Brain-Computer Interface Sector: A Guide to A-Share Market Leaders Across the Full Industry Chain

Scholar Rock Holding Price Target Maintained with a $58.00/share by Wedbush

Alkermes Plc : Leerink Partners Raises Target Price to $50 from $34

THOMSON REUTERS

Switzerland's Novartis Beats Q2 Sales Estimates on Strong Sales Across Priority Brands

Sweden's Medcap Q2 Net Sales Rise 16% on Organic Growth and Acquisitions

Scholar Rock Says EU Opinion on SMA Drug May be Pushed to Later in 2026

China's Ministry of Industry and Information Technology Aims to Drive Widespread Adoption of Humanoid Robots and Brain-Computer Interfaces

Scholar Rock provides update on timing of CHMP opinion for apitegromab MAA

Scholar Rock Announces Press Release on Apitegromab CHMP Opinion Timing for SMA MAA

Scholar Rock Provides Update on Timing of Committee for Medicinal Products for Human Use (chmp) Opinion for Apitegromab Marketing Authorisation Application (maa) for Spinal Muscular Atrophy (sma)

THOMSON REUTERS

Scholar Rock Holding Corp - Apitegromab Chmp Opinion Expected After Catalent Indiana Classification or Second Facility Inclusion

THOMSON REUTERS

Scholar Rock Holding Corp - Apitegromab Bla Under FDA Review with Sept 30, 2026 Pdufa Date

THOMSON REUTERS

Alkermes Plc : Stifel Raises Target Price to $63 from $45

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Alkermes (ALKS)

Praxis Precision Medicines (PRAX) Could Be 49% Undervalued As Patch Deal Expands Ulixacaltamide Reach

Simply Wall St.

Wuxi Ranks Among China's Top Ten Happiest Cities Once Again

Scholar Rock Reports New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

17-Year Research Effort Solves Medical Power Challenge: Wang Zhonglin's Team Achieves Breakthrough in Self-Powering Human Heart Pacemakers, with Potential for Brain-Computer Interfaces

Scholar Rock to Report Q2 2026 Financial Results, Host Conference Call

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/IBRN/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","market":"US","secType":"STK","nameCN":"iShares Neuroscience and Healthcare ETF","latestPrice":38.95,"timestamp":1788550698477,"preClose":39.3744,"halted":0,"volume":893,"delay":0,"changeRate":-0.010778576943394656,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"Trading","change":-0.4244,"latestTime":"09-04 15:40:55 EDT","open":38.97,"high":38.97,"low":38.95,"amount":34814.26582,"amplitude":0.000508,"askPrice":39.14,"askSize":300,"bidPrice":38.87,"bidSize":300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788552000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":39.3744,"sharesOutstanding":150000,"nav":39.408165,"aum":7881633,"dividendRate":0.008203,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":39.38,"preClose":39.3744,"latestTime":"16:10 EDT","volume":6,"amount":235.9776,"timestamp":1788466204933,"change":0.0056,"changeRate":0.000142,"amplitude":0},"volumeRatio":0.226605,"impliedVol":0.0707,"impliedVolPercentile":0.246},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.226605,"shares":200000,"dividePrice":0.3195,"high":38.97,"amplitude":0.000508,"preClose":39.3744,"low":38.95,"week52Low":25.4196,"pbRate":"--","week52High":43.01,"institutionHeld":0,"latestPrice":38.95,"eps":0,"divideRate":0.008203,"volume":893,"delay":0,"ttmEps":0,"open":38.97,"prevYearClose":32.3193,"prevWeekClose":39.2301,"prevMonthClose":38.9601,"prevQuarterClose":38.8263,"fiveDayClose":39.2301,"twentyDayClose":38.8576,"sixtyDayClose":33.9605},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRN\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"IBRN","amount":0.319807,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2024-12-17","symbol":"IBRN","amount":0.10114,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2023-12-20","symbol":"IBRN","amount":0.006303,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"IBRN","amount":0.008241,"announcedDate":"2023-05-12","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRN\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.008241,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.006303,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.10114,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-19","value":0.319807,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRN\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653163847","title":"Netherlands' Argenx Q2 Net Sales Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2653163847","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653163847?lang=en_us&edition=fundamental","pubTime":"2026-07-23 13:13","pubTimestamp":1784783626,"startTime":"0","endTime":"0","summary":"Netherlands' Argenx Q2 net sales riseOverviewNetherlands immunology firm's Q2 product net sales rose 60% yr/yr and 17% sequentiallyQ2 net profit and EPS more than doubled from prior yearGrowth driven ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nL1N43P04Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","IBRN","BK4139","SRRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196931182","title":"Neuralink's Soaring Valuation Ignites the Brain-Computer Interface Sector: A Guide to A-Share Market Leaders Across the Full Industry Chain","url":"https://stock-news.laohu8.com/highlight/detail?id=1196931182","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196931182?lang=en_us&edition=fundamental","pubTime":"2026-07-22 22:41","pubTimestamp":1784731299,"startTime":"0","endTime":"0","summary":"Global capital is making significant bets on brain-computer interface (BCI) technology, accelerating its industrialization cycle. The secondary market valuation of Elon Musk's Neuralink has surged to...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653033932","title":"Scholar Rock Holding Price Target Maintained with a $58.00/share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2653033932","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653033932?lang=en_us&edition=fundamental","pubTime":"2026-07-21 21:41","pubTimestamp":1784641260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SRRK/analyst-ratings(END) Dow Jones NewswiresJuly 21, 2026 09:41 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","THNR","SRRK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653277231","title":"Alkermes Plc : Leerink Partners Raises Target Price to $50 from $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2653277231","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653277231?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:34","pubTimestamp":1784637260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0YI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","PSIL","ALKS","MEDX","IBRN","PSCH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653225766","title":"Switzerland's Novartis Beats Q2 Sales Estimates on Strong Sales Across Priority Brands","url":"https://stock-news.laohu8.com/highlight/detail?id=2653225766","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653225766?lang=en_us&edition=fundamental","pubTime":"2026-07-21 13:12","pubTimestamp":1784610770,"startTime":"0","endTime":"0","summary":"Switzerland's Novartis beats Q2 sales estimates on strong sales across priority brandsOverviewSwitzerland-based innovative medicines firm's Q2 net sales rose 3%, beating analyst expectationsCore EPS f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL1N43N03R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","SRRK","BK4139","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653583225","title":"Sweden's Medcap Q2 Net Sales Rise 16% on Organic Growth and Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2653583225","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653583225?lang=en_us&edition=fundamental","pubTime":"2026-07-21 12:40","pubTimestamp":1784608831,"startTime":"0","endTime":"0","summary":"Sweden's MedCap Q2 net sales rise 16% on organic growth and acquisitionsOverviewSweden-based life sciences investor's Q2 net sales rose 16%, driven by organic growth and acquisitionsAdjusted EBITA inc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL1N43N02W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRRK","IBRN","THNR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652212521","title":"Scholar Rock Says EU Opinion on SMA Drug May be Pushed to Later in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2652212521","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652212521?lang=en_us&edition=fundamental","pubTime":"2026-07-20 23:37","pubTimestamp":1784561821,"startTime":"0","endTime":"0","summary":"CORRECTED-Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026July 20 (Reuters)-Scholar RockSRRK.Osaid on Monday a European Union opinion on its experimental spinal muscular atrophy","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nL4N43M11G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRN","THNR","SRRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198648310","title":"China's Ministry of Industry and Information Technology Aims to Drive Widespread Adoption of Humanoid Robots and Brain-Computer Interfaces","url":"https://stock-news.laohu8.com/highlight/detail?id=1198648310","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198648310?lang=en_us&edition=fundamental","pubTime":"2026-07-20 22:21","pubTimestamp":1784557280,"startTime":"0","endTime":"0","summary":"China's Ministry of Industry and Information Technology (MIIT) convened a significant national forum on July 20th, bringing together key leaders from industrial and information technology...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UBOT","IQM","ROBT","MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652821343","title":"Scholar Rock provides update on timing of CHMP opinion for apitegromab MAA","url":"https://stock-news.laohu8.com/highlight/detail?id=2652821343","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652821343?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:10","pubTimestamp":1784549431,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) provided an update on the anticipated timing of a Committee for Medicinal Products for Human Use, CHMP, opinion for the apitegr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-provides-update-on-timing-of-chmp-opinion-for-apitegromab-maa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-provides-update-on-timing-of-chmp-opinion-for-apitegromab-maa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPRE","BK4585","CHMP","SRRK","IBRN","BK4139","MAA","THNR","BK4215","BK4087","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652329213","title":"Scholar Rock Announces Press Release on Apitegromab CHMP Opinion Timing for SMA MAA","url":"https://stock-news.laohu8.com/highlight/detail?id=2652329213","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652329213?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:05","pubTimestamp":1784549101,"startTime":"0","endTime":"0","summary":"Scholar Rock announces press release on apitegromab CHMP opinion timing for SMA MAAScholar Rock flagged a delay risk for an EMA CHMP opinion on apitegromab’s MAA in spinal muscular atrophy.Timing hing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL4pqJxq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","SRRK","IBRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652793218","title":"Scholar Rock Provides Update on Timing of Committee for Medicinal Products for Human Use (chmp) Opinion for Apitegromab Marketing Authorisation Application (maa) for Spinal Muscular Atrophy (sma)","url":"https://stock-news.laohu8.com/highlight/detail?id=2652793218","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652793218?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:00","pubTimestamp":1784548803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUA65GXS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","BK4139","SRRK","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652218722","title":"Scholar Rock Holding Corp - Apitegromab Chmp Opinion Expected After Catalent Indiana Classification or Second Facility Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=2652218722","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652218722?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:00","pubTimestamp":1784548803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUA65GXS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","SRRK","BK4139","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652187402","title":"Scholar Rock Holding Corp - Apitegromab Bla Under FDA Review with Sept 30, 2026 Pdufa Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2652187402","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652187402?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:00","pubTimestamp":1784548803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUA65GXS:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SRRK","THNR","IBRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652290391","title":"Alkermes Plc : Stifel Raises Target Price to $63 from $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2652290391","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652290391?lang=en_us&edition=fundamental","pubTime":"2026-07-20 19:09","pubTimestamp":1784545792,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nFWN43M0KM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","BK4139","ALKS","PSIL","FBT","MEDX","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652329784","title":"Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Alkermes (ALKS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2652329784","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652329784?lang=en_us&edition=fundamental","pubTime":"2026-07-20 18:30","pubTimestamp":1784543447,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Harmony Biosciences Holdings (HRMY) and Alkermes (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0029874061.USD","BK4007","HRMY","PSIL","MEDX","ALKS","PSCH","BK4137","HCSG","BK4581","XLV","BK4139","LABU","FBT","LU0128526141.USD","IBRN","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652261765","title":"Praxis Precision Medicines (PRAX) Could Be 49% Undervalued As Patch Deal Expands Ulixacaltamide Reach","url":"https://stock-news.laohu8.com/highlight/detail?id=2652261765","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652261765?lang=en_us&edition=fundamental","pubTime":"2026-07-20 11:30","pubTimestamp":1784518237,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines (PRAX) drew fresh investor attention after announcing a research collaboration and license agreement with Remagine Labs to develop a multi day iontophoretic transdermal patch for ulixacaltamide in essential tremor.\nSee our latest analysis for Praxis Precision Medicines.\nThe latest collaboration news arrives after a period of mixed momentum for Praxis Precision Medicines, with the share price up 11.37% over 30 days but down 8.22% over 90 days, while the 1 year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prax/praxis-precision-medicines/news/praxis-precision-medicines-prax-could-be-49-undervalued-as-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prax/praxis-precision-medicines/news/praxis-precision-medicines-prax-could-be-49-undervalued-as-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","IE0002141913.USD","LU0109394709.USD","LU0320765992.SGD","IBRN","IE00B4R5TH58.HKD","PRAX","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163331797","title":"Wuxi Ranks Among China's Top Ten Happiest Cities Once Again","url":"https://stock-news.laohu8.com/highlight/detail?id=1163331797","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163331797?lang=en_us&edition=fundamental","pubTime":"2026-07-18 12:31","pubTimestamp":1784349079,"startTime":"0","endTime":"0","summary":"Wuxi has once again been recognized as one of China's happiest cities.According to a recent ranking of the top ten happiest cities in China for 2026, Wuxi secured the sixth position nationally. This...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652280735","title":"Scholar Rock Reports New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2652280735","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652280735?lang=en_us&edition=fundamental","pubTime":"2026-07-18 04:15","pubTimestamp":1784319300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA73GYT2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","THNR","IBRN","SRRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115852772","title":"17-Year Research Effort Solves Medical Power Challenge: Wang Zhonglin's Team Achieves Breakthrough in Self-Powering Human Heart Pacemakers, with Potential for Brain-Computer Interfaces","url":"https://stock-news.laohu8.com/highlight/detail?id=1115852772","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115852772?lang=en_us&edition=fundamental","pubTime":"2026-07-17 12:20","pubTimestamp":1784262050,"startTime":"0","endTime":"0","summary":"After 17 years of dedicated research, a significant medical power supply challenge has been overcome. A team led by Academician Wang Zhonglin has successfully achieved a breakthrough in self-powering...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNTL","159891","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651441518","title":"Scholar Rock to Report Q2 2026 Financial Results, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2651441518","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651441518?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:00","pubTimestamp":1784203241,"startTime":"0","endTime":"0","summary":"Scholar Rock to report Q2 2026 financial results, host conference callScholar Rock schedules Q2 2026 financial results release for Aug. 6, 2026, before the U.S. market open.Conference call, webcast se","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL9TCQtB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRRK","IBRN","THNR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}